Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | L'Oréal SA | 1,097 |
| 2 | Roche Holding AG | 761 |
| 3 | DSM Firmenich AG | 614 |
| 4 | Nestle SA | 589 |
| 5 | Symrise AG | 443 |
| 6 | Unilever PLC | 412 |
| 7 | Pfizer Inc | 403 |
| 8 | Kenvue Inc | 378 |
| 9 | BASF SE | 340 |
| 10 | British American Tobacco PLC | 318 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 37,942 |
| 2 | A61P | Therapeutic activity (drug indications) | 27,796 |
| 3 | A61Q | Cosmetics, personal care | 12,373 |
| 4 | A23L | Foods and beverages (general) | 8,838 |
| 5 | A23V | Foods, foodstuffs - indexing scheme | 6,282 |
| 6 | C07D | Heterocyclic compounds | 5,669 |
| 7 | C12N | Microorganisms, enzymes | 5,388 |
| 8 | C07K | Peptides | 3,820 |
| 9 | G01N | Investigating / analysing materials | 3,381 |
| 10 | Y02A | Climate change adaptation | 3,251 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Pharmaceutical formulations of resveratrol and methods of use thereof | 2002 | Joddes Ltd | 200 |
| Administration of resveratrol to prevent or treat restenosis following coronary intervention | 2001 | Joddes Ltd | 182 |
| THE USE OF RESVERATROL TO REGULATE EXPRESSION OF APOLIPOPROTEIN A1 | 2004 | 117 | |
| Administration of resveratrol to treat inflammatory respiratory disorders | 2005 | IP Group PLC | 107 |
| Compositions based on resveratrol | 2003 | 97 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 682 |
| 2017 | 753 |
| 2018 | 674 |
| 2019 | 738 |
| 2020 | 736 |
| 2021 | 624 |
| 2022 | 659 |
| 2023 | 600 |
| 2024 | 592 |
| 2025 | 239 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Dipak K. Das | University of Connecticut | 44 |
| 2 | John M. Pezzuto | University of Hawaii at Hilo | 33 |
| 3 | Rafael de Cabo | National Institute on Aging | 24 |
| 4 | Thomas Szekeres | Medical University of Vienna | 19 |
| 5 | Joseph A. Baur | University of Pennsylvania | 19 |
| 6 | Dominique Delmas | Université de Bourgogne | 19 |
| 7 | Norbert Latruffe | Université de Bourgogne | 18 |
| 8 | Ki Won Lee | Konkuk University | 16 |
| 9 | Qingyong Ma | First Affiliated Hospital of Xi'an Jiaotong University | 15 |
| 10 | Beata Olas | University of Łódź | 15 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Dose translation from animal to human studies revisited | 2007 | 6457 | Sirtuins and Resveratrol in Medicine |
| Resveratrol improves health and survival of mice on a high-calorie diet | 2006 | 4256 | Genetics, Aging, and Longevity in Model Organisms |
| Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α | 2006 | 4024 | Sirtuins and Resveratrol in Medicine |
| Therapeutic potential of resveratrol: the in vivo evidence | 2006 | 3938 | Sirtuins and Resveratrol in Medicine |
| Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan | 2003 | 3790 | Genetics, Aging, and Longevity in Model Organisms |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of resveratrol?
Which organizations hold the most patents on resveratrol?
How has patent and publication activity for resveratrol changed in recent years?
Which academic researchers have published the most on resveratrol?
What are the primary patent classifications associated with resveratrol intellectual property?